NCT03470779

Brief Summary

The aim of this study is to assess the impact and feasibility of an interdisciplinary group treatment approach, involving psychotherapy and physiotherapy, with survivors of torture that are incarcerated in a prison in Kurdistan, Iraq. The primary aim is to develop initial estimates of treatment effects on symptoms and poor functioning consistent with centralized pain and post-traumatic stress disorder, anxiety, and/or depression. The secondary aim is to assess the feasibility of studying this interdisciplinary treatment program in which local Kurdish psychotherapists and physiotherapists provide a 10-week intervention in a prison, in the Kurdish Sorani language, and to Kurdish participants that present with mental health symptoms, physical complaints, and poor functioning

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 20, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

April 19, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

March 13, 2019

Status Verified

March 1, 2019

Enrollment Period

7 months

First QC Date

March 13, 2018

Last Update Submit

March 11, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hopkins Symptom Checklist-25

    The HSCL-25 is a 25-question symptom inventory which measures symptoms of anxiety and depression.

    10 weeks

Secondary Outcomes (6)

  • Patient Specific Functional Scale

    10-weeks

  • Pittsburgh Sleep Quality Index

    10-weeks

  • Patient's Global Impression of Change Scale

    10-weeks

  • General Self Efficacy Scale

    10-weeks

  • Central Sensitization Inventory

    10-weeks

  • +1 more secondary outcomes

Study Arms (2)

Treatment group

EXPERIMENTAL

Participants randomly assigned to the treatment group will participate in an interdisciplinary treatment program in which local Kurdish psychotherapists and physiotherapists provide a 10-week intervention program. Treatment will consist of group physiotherapy and group psychotherapy

Other: PhysiotherapyOther: Psychotherapy

Wait-list group

NO INTERVENTION

Participants randomly assigned to the wait-list group will not receive treatment but will participate in outcome data collection for comparison purposes.

Interventions

Treatment group participants will participate in weekly group physiotherapy and psychotherapy sessions as part of the standard program procedure.

Treatment group

Treatment group participants will participate in weekly group physiotherapy and psychotherapy sessions as part of the standard program procedure.

Treatment group

Eligibility Criteria

Age18 Years - 100 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsThis program and study are being administered in an all-male reformatory. Thus, only men are being studied.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age equal to or greater than 18 years
  • Incarcerated in the reformatory where research is conducted
  • Native speaker of Sorani, a Kurdish language
  • History of torture is reported and documented during the psychotherapy intake
  • Presents with symptoms consistent with post-traumatic stress disorder, anxiety, and/or depression evident by a total score of greater than or equal to 1.75 on Hopkins Symptoms Checklist-25 and/or by a total score greater than or equal to 2.5 on the Harvard Trauma Questionnaire Part 4
  • Presents with symptoms consistent with centralized pain evident by a score of greater than or equal to 40 on the Central Sensitization Inventory Part A.

You may not qualify if:

  • Reports he will not remain in the current reformatory for at least 6 months from the onset of the study
  • Is unable to make the time commitment required to participate
  • Presents with symptoms consistent with a psychiatric condition which makes participation in the study unsafe for himself or others, based on the evaluation by the treating psychotherapist
  • Presents with a high risk to self or others which makes participation in the study unsafe for himself or others, based on evaluation by the treating psychotherapist
  • Participation is deemed unsafe due to a severe medical condition previously diagnosed by a medical doctor and/or signs/symptoms consistent with a possible medical condition based on the evaluation by the treating physiotherapist, 6.) reports previously receiving treatment by Wchan
  • Current substance abuse reported by participant or identified by treating psychotherapist
  • Currently receiving mental health services and/or physiotherapy services from other organization
  • Reports unresolvable conflict with participant/s enrolled in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sulaymaniyah Adult Male Reformatory

Sulaymaniyah, Kurdistan, Iraq

Location

MeSH Terms

Conditions

Somatoform Disorders

Interventions

Physical Therapy ModalitiesPsychotherapy

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitationBehavioral Disciplines and Activities

Study Officials

  • Jeff A Hartman, DPT, MPH

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study design is a randomized, wait-list controlled pilot study. A parallel group study design will be used to compare a treatment group and a wait-list control group. This study design will be effective for addressing the gap in literature by examining both the initial treatment estimates related to health and functioning and the feasibility of performing a similar study on a larger scale.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

March 13, 2018

First Posted

March 20, 2018

Study Start

April 19, 2018

Primary Completion

November 15, 2018

Study Completion

January 1, 2019

Last Updated

March 13, 2019

Record last verified: 2019-03

Locations